期刊文献+

前列腺特异抗原联合分级对前列腺癌患者分期的预测 被引量:9

Prediction of the stage of patients with prostate cancer by the combination of serum prostate specific antigen and Gleason score
原文传递
导出
摘要 目的探讨血清前列腺特异抗原(PSA)联合分级对前列腺癌患者的分期进行预测的方法。方法回顾分析我院泌尿外科187例穿刺活检诊断为前列腺癌患者的临床资料。采用等级相关分析、秩和检验、逐步判别多因素分析方法,分析血清PSA水平、游离PSA百分比(FPSA/TPSA值)与Gleason评分(GS)、分期的关系。结果前列腺癌患者GS越高,血清PSA水平越高(r=0.369,P〈0.001)。分期越晚,血清PSA、GS越高(r=0.398,0.530,P均〈0.001)。FPSA/TPSA值与分期不相关(P〉0.70),但当PSA≤10μg/L时,FPSA/TPSA值与分期呈负相关(r=-0.600,P〈0.05)。当PSA〉20μg/L时,67%~87%的患者可能为C或D期。用PSA、GS预测分期的公式为x=-3.488+0.041×PSA+0.428×GS。结论血清PSA水平与GS呈正相关。血清PSA水平、GS分别与分期呈正相关。当PSA≤10μg/L时,FPSA/TPSA值与分期呈负相关。运用判别公式x=-3.488+0.041×PSA+0.428×GS可以预测前列腺癌患者的分期。 Objective To explore the method of predicting the stage of prostate cancer with serum prostate-specific antigen(PSA) and pathological grade. Methods One hundred and eithty-seven patients were studied retrospectively with prostate cancer diagnosed by systemic biopsy in our hospital. The rank correlation analysis, rank sum test and stepwise discriminant multivariate analysis were used to assess the correlation of serum PSA level, ratio of free PSA to total PSA( FPSA/TPSA ratio) with Gleason score (GS) and stage. Results Serum PSA level increased with GS for prostate cancer patients ( r = 0. 369, P 〈 0. 001 ). With increasing stage, serum PSA level and GS increased (r =0. 398,0. 530,P 〈0. 001). Overall, FPSA/ TPSA ratio was not correlated with stage ( P 〉 0. 70), but a significant negative correlation was demonstrated between them when serum PSA ≤10 μg/L( r = - 0. 600, P 〈 0. 05 ). When serum PSA 〉 20 μg/L, 67% - 87% patients with prostate cancer may be stage C or D. The equation using serum PSA and GS to predict the stage of patients with prostate cancer was : x = - 3.488 + 0. 041 × PSA + 0. 428 × GS. Conclusions Serum PSA level is positively correlated with GS for prostate cancer patients. Serum PSA level and GS are positively correlated with stage. A negative correlation between FPSA/TPSA ratio and stage is demonstrated when serum PSA ≤ 10 μg/L. The combination of serum PSA and GS may predict the stage of patients with prostate cancer.
出处 《中华外科杂志》 CAS CSCD 北大核心 2006年第6期376-378,共3页 Chinese Journal of Surgery
关键词 前列腺肿瘤 前列腺特异抗原 GLEASON评分 肿瘤分期 Prostatic neoplasms Prostate-specific antigen Gleason score Neoplasm staging
  • 相关文献

参考文献10

  • 1周利群,陈为民,那彦群,黄有媛,冯陶,郝金瑞,潘柏年,薛兆英,顾方六,郭应禄.良性前列腺增生患者血清PSA与年龄变化的关系[J].中华泌尿外科杂志,2002,23(5):293-295. 被引量:38
  • 2Lerner SE,Jacobsen SJ,Lilja H,et al.Free,complexed,and total serum prostate-specific antigen concentrations and their proportions in predicting stage,grade,and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate.Urology,1996,48:240-248.
  • 3Babaian RJ,Camps JL,Frangos DN,et al.Monoclonal prostate-specific antigen in untreated prostate cancer.Relationship to clinical stage and grade.Cancer,1991,67:2200-2206.
  • 4Poter JR,Brawer MK.Prostatic intraepithelial neoplasia and prostate-specific antigen.World J Urol,1993,11:196-200.
  • 5Bigler SA,Deering RE,Brawer MK.Comparison of microscopic vascularity in benign and malignant prostate tissue.Hum Pathol,1993,24:220-226.
  • 6Stege RH,Tribukait B,Carlstrom KA,et al.Tissue PSA from fine-needle biopsies of prostatic carcinoma as related to serum PSA,clinical stage,cytological grade,and DNA ploidy.Prostate,1999,38:183-188.
  • 7Zagars GK,Sherman NE,Babaian RJ.Prostate-specific antigen and external beam radiation therapy in prostate cancer.Cancer,1991,67:412-420.
  • 8周利群,陈为民,那彦群,黄有媛,冯陶,郝金瑞,潘柏年,薛兆英,顾方六,郭应禄.良性前列腺增生与前列腺癌患者血清总PSA水平与游离PSA比值的比较[J].中华泌尿外科杂志,2002,23(6):354-357. 被引量:74
  • 9Tombal B,Querton M,Nayer P,et al.Free/total PSA ratio does not improve prediction of pathologic stage and biochemical recurrence after radical prostatectomy.Urology,2002,59:256-260.
  • 10Partin AW,Mangold LA,Lamm DM,et al.Contemporary update of prostate cancer stanging nomograms (Partin Tables) for the new millennium.Urology,2001,58:843-848.

二级参考文献9

  • 1Carter HB,Pearson JD,Metter EJ,et al.Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease[].The Journal of The American Medical Association.1992
  • 2Christensson A,Bjork T,Nilsson O,et al.Serum prostate specific antigen complexed to alpha1 - antichymotrypsin as an indicator of prostate cancer[].Journal d Urologie.1993
  • 3Oesterling JE,Jacobsen SJ,Chute CG,et al.Serum prostate-specific antigen in a commuinity-based population of healthy men[].The Journal of The American Medical Association.1993
  • 4Collins GN,Martin PJ,Wynn-Davies A,et al.The effect of dig-ital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free- to- total prostate specific antigen ratio in clinical practice[].Journal d Urologie.1997
  • 5Robles JM,Morell AR,Redorta JP,et al.Clinical behavior of prostate specific antigen and prostatic acid phosphotase: a comparative study[].European Urology.1988
  • 6Glenski WJ,Malek RS,Myrtle JF,et al.Sustained, sunstantially increased concentration of prostate-specific antigen in the absence of prostatic malignant disease: an unusual clinical scenario[].Mayo Clinic Proceedings.1992
  • 7Brawer MK.Prostatic intraepithelial neoplasia and prostatic-specific antigen[].Urology.1989
  • 8Benson MC,Whang IS,Pantuck A,et al.Prostate specific antigen density: a means of distinguishing benign prostatic hypertraphy and prostate cancer[].Journal d Urologie.1992
  • 9杨柳平.游离PSA百分率的临床研究进展[J].国外医学(泌尿系统分册),1998,18(1):33-35. 被引量:22

共引文献108

同被引文献99

引证文献9

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部